Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma-Reference-Cited by-同舟云学术

Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma

Published:2017-04-27 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Blank Oliver¹,von Tresckow Bastian²,Monsef Ina¹,Specht Lena³,Engert Andreas²,Skoetz Nicole¹

Affiliation:

1. University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50937

2. University Hospital of Cologne; Department I of Internal Medicine; Cologne Germany 50931

3. Rigshospitalet, University of Copenhagen; Depts. of Oncology and Haematology; The Finsen Centre 9 Blegdamsvej Copenhagen Denmark DK-2100

Publisher

Wiley

Subject

Pharmacology (medical)

Reference123 articles.

1. Bloomfield CD Pajak TF Glicksman AS Gottlieb AJ Coleman M Nissen NI Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies Cancer Treatment Reports 1982 835 46

2. Comparson of three radiation dose levels after EBVP regimen in favourable supradiaphragmatic clinical stages (CS) I-II Hodgkin's lymphoma (HL): Preliminary results of EORTC-GELA H9-F trial;Eghbali;Blood,2005

3. Noordijk EM Thomas J Ferme C van 't Veer MB Brice P Divine M First results of EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favourable or unfavourable early stage Hodgkin's lymphoma (HL) Journal of Clinical Oncology 2005 abstract 6505

4. Noordijk EM Thomas J Fermé C Van't Veer MB Brice P Divine M First results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable or unfavorable early stage Hodgkin's lymphoma (HL) ASCO Annual Meeting Presentation Slides YR:2005

5. Six cycles of EBVP followed by 36 Gy involvedfield irradiation vs. no irradiation in favourable supradiaphragmatic clinical stages III Hodgkin's lymphoma: the EORTCGELA strategy in 771 patients (H9-F trial-20982) [Abstract AE11a];Thomas;European Journal of Haematology,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of familial predisposition to heart failure to the risk of anthracycline-related cardiotoxicity: A nationwide study;American Heart Journal;2023-11

2. Patterns of care and outcomes of early stage I–II Hodgkin lymphoma treated with or without radiation therapy;Leukemia & Lymphoma;2022-07-29

3. Radiotherapy of lymphomas;Cancer/Radiothérapie;2022-02

4. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis;BMC Cancer;2021-08-25

5. Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies;Cochrane Database of Systematic Reviews;2020-01-13